Bioage Labs, Stock Price on November 22, 2024

BIOA Stock   18.80  0.49  2.54%   
If you're considering investing in BioAge Stock, it is important to understand the factors that can impact its price. As of today, the current price of BioAge Labs, stands at 18.80, as last reported on the 30th of November, with the highest price reaching 19.53 and the lowest price hitting 18.78 during the day. BioAge Labs, appears to be somewhat reliable, given 3 months investment horizon. BioAge Labs, secures Sharpe Ratio (or Efficiency) of 0.0369, which signifies that the company had a 0.0369% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for BioAge Labs,, which you can use to evaluate the volatility of the firm. Please makes use of BioAge Labs,'s Mean Deviation of 4.03, downside deviation of 5.51, and Risk Adjusted Performance of 0.0368 to double-check if our risk estimates are consistent with your expectations.
  
The current year's Stock Based Compensation is expected to grow to about 3.7 M, whereas Total Stockholder Equity is projected to grow to (164.7 M). . At present, BioAge Labs,'s Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 33.21, whereas Price To Sales Ratio is forecasted to decline to 56.15. BioAge Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0369

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsBIOA
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.37
  actual daily
47
53% of assets are more volatile

Expected Return

 0.2
  actual daily
3
97% of assets have higher returns

Risk-Adjusted Return

 0.04
  actual daily
2
98% of assets perform better
Based on monthly moving average BioAge Labs, is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of BioAge Labs, by adding it to a well-diversified portfolio.
Book Value
(114.37)
Enterprise Value
539 M
Shares Float
1.2 M
Shares Outstanding
34.2 M
Market Capitalization
674.1 M

Related Headline

Stepstone Headline on 22nd of November 2024

StepStone Group had its price target upped by The Goldman Sachs Group from 64.00 to 70.50 in a research note issued to investors on Tuesday morning,Benzinga reports. The Goldman Sachs Group currently has a neutral rating on the stock. Other analysts have also issued reports about the company. JPMorgan Chase

BioAge Labs, Valuation on November 22, 2024

It is possible to determine the worth of BioAge Labs, on a given historical date. On November 22, 2024 BioAge was worth 18.72 at the beginning of the trading date compared to the closed value of 19.14. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of BioAge Labs, stock. Still, in general, we apply an absolute valuation method to find BioAge Labs,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of BioAge Labs, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against BioAge Labs,'s related companies.
 Open High Low Close Volume
  18.35    19.39    18.10    18.44    215,557  
11/22/2024
  18.72    19.33    18.70    19.14    184,301  
  19.15    19.64    18.47    19.07    292,115  
Backtest BioAge Labs,  |  BioAge Labs, History  |  BioAge Labs, Valuation   PreviousNext  
Open Value
18.72
19.14
Closing Value
34.84
Upside

BioAge Labs, Trading Date Momentum on November 22, 2024

On November 25 2024 BioAge Labs, was traded for  19.07  at the closing time. The top price for the day was 19.64  and the lowest listed price was  18.47 . The trading volume for the day was 292.1 K. The trading history from November 25, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 0.37% . The overall trading delta against the current closing price is 0.84% .

BioAge Labs, Fundamentals Correlations and Trends

By evaluating BioAge Labs,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among BioAge Labs,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. BioAge financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About BioAge Labs, Stock history

BioAge Labs, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for BioAge is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in BioAge Labs, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing BioAge Labs, stock prices may prove useful in developing a viable investing in BioAge Labs,
Last ReportedProjected for Next Year
Common Stock Shares Outstanding38.7 M35.8 M

BioAge Labs, Stock Technical Analysis

BioAge Labs, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of BioAge Labs, technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of BioAge Labs, trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

BioAge Labs, Period Price Range

Low
November 30, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

BioAge Labs, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

BioAge Labs, November 30, 2024 Market Strength

Market strength indicators help investors to evaluate how BioAge Labs, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BioAge Labs, shares will generate the highest return on investment. By undertsting and applying BioAge Labs, stock market strength indicators, traders can identify BioAge Labs, entry and exit signals to maximize returns

BioAge Labs, Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for BioAge Labs,'s price direction in advance. Along with the technical and fundamental analysis of BioAge Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of BioAge to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for BioAge Stock analysis

When running BioAge Labs,'s price analysis, check to measure BioAge Labs,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAge Labs, is operating at the current time. Most of BioAge Labs,'s value examination focuses on studying past and present price action to predict the probability of BioAge Labs,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAge Labs,'s price. Additionally, you may evaluate how the addition of BioAge Labs, to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation